[Translated article] Multidisciplinary approach to prenatal cystic fibrosis with cystic fibrosis transmembrane regulator modulators: Experience in a clinical case [0.03%]
多学科方法在产前囊性纤维化与囊性纤维化跨膜调节物调制剂中的应用：一例临床病例经验总结
Pedro Del Palacio-García,Carmen García-Muñoz,María Dolores Canales-Siguero et al.
Pedro Del Palacio-García et al.
[Translated article] Acute esophageal necrosis in a patient with lung cancer under treatment with osimertinib: Case report [0.03%]
奥希替尼治疗肺癌患者的急性食管坏死1例报告
Alicia Aguado-Paredes,Laura Moñino-Dominguez,Maria Del Carmen Damas-Fuentes
Alicia Aguado-Paredes
Atezolizumab plus platinum-based chemotherapy and etoposide as first-line treatment for metastatic small cell lung cancer: a retrospective multicenter observational study [0.03%]
阿特珠单抗联合以铂类药物为基础的化疗及依托泊苷治疗小细胞肺癌患者的首次经验：一项回顾性多中心观察研究
Laura Moñino Domínguez,Laura Amaro Álvarez,Alicia Aguado Paredes et al.
Laura Moñino Domínguez et al.
Introduction: The standard first-line treatment for metastatic small-cell lung cancer (SCLC) is platinum-based chemotherapy in combination with etoposide. The aim of this study was to evaluate the real-world effectiveness...
Professional profile and expectations of members associated to Pharmaceutical Care in Infectious Diseases group of the Spanish Society of Hospital Pharmacy [0.03%]
西班牙医院药学学会感染病药物治疗组成员的职业档案及期望值
Iván Oterino-Moreira,Álvaro-Eloy Monje-López,Beatriz Mejuto et al.
Iván Oterino-Moreira et al.
Background: The Pharmaceutical Care in Infectious Diseases Group (AFinf) is composed of a coordinating group of 11 pharmacists, 1 fellow, 1 resident pharmacist intern, 4 senior consultants and 221 associate members (July ...
Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer [0.03%]
度伐利尤单抗联合卡铂和依托泊苷治疗广泛期小细胞肺癌的疗效和安全性分析
María Belén Aznar de la Riera,Carmen María Valencia Soto,Adela García-Avello Fernández-Cueto et al.
María Belén Aznar de la Riera et al.
Objective: The objective is to describe the real-world effectiveness and safety of atezolizumab in combination with carboplatin and etoposide as first-line treatment for patients with extensive-stage small-cell lung cance...
Application of the Basel Statements self-assessment questionnaire in eight hospitals in Latin America [0.03%]
巴塞尔声明自我评估问卷在拉丁美洲8家医院的应用
Esteban Zavaleta-Monestel,Arturo Villalobos-Madriz,Abigail Fallas-Mora et al.
Esteban Zavaleta-Monestel et al.
The standardization of hospital pharmacy practice remains a challenge in Latin America due to the heterogeneity of healthcare systems. The Basel Statements, developed by the International Pharmaceutical Federation, provide guidelines aimed ...
Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice [0.03%]
用于年龄相关性黄斑变性的faricimab给药间隔优化和治疗依从性：真实世界临床实践中的观察性研究
Silvia Cornejo-Uixeda,Joaquín Borrás-Blasco,Alejandro Valcuende-Rosique et al.
Silvia Cornejo-Uixeda et al.
Objective: To evaluate treatment persistence and dosing interval extension with faricimab in neovascular age-related macular degeneration (nAMD) in real-world practice. ...
Safety of Bruton kinase inhibitors in chronic lymphocytic leukemia: Real world clinical practice [0.03%]
布鲁顿酪氨酸激酶抑制剂在慢性淋巴细胞白血病患者中的安全性：临床实践报告
Rocío Bello-Calvo,Rita González-Resina,Araceli Rubio-Martínez et al.
Rocío Bello-Calvo et al.
Introduction: Bruton's tyrosine kinase inhibitors (BTKi) have replaced immunochemotherapy in patients with chronic lymphocytic leukemia (CLL). The safety profile, particularly in monotherapy indications under real-world c...
In vitro assay of pharmacobezoar formation with extended-release divalproex sodium tablets [0.03%]
宁格替必片剂体外药块形成试验研究
Thais Lizondo López,Silvia González Suárez,Carmen López-Cabezas et al.
Thais Lizondo López et al.
Objective: To assess pharmacobezoar formation in a case of intoxication following the massive ingestion of extended-release divalproex sodium tablets, using an in vitro model conducted in the pharmacy laboratory. ...
Sterility of repackaged faricimab for intravitreal administration [0.03%]
预充式注射器远藤素单抗的无菌保障水平验证研究报告摘要
Antonio Raymundo,Lourdes Cervera,Francisco Crespillo et al.
Antonio Raymundo et al.
Objectives: New drugs such as faricimab have been developed to treat ophthalmic neovascular diseases. While these drugs increase treatment success, they also increase costs. Repackaging drugs strikes a balance between tec...